Phase I trial of fixed dose rate infusion (FDRI) gemcitabine (GEM) with gefitinib in patients with advanced pancreatic carcinoma.

被引：0
|
作者：
Carneiro, B [1 ]
Brand, R [1 ]
Fine, E [1 ]
Knop, R [1 ]
Khandekar, J [1 ]
Uhlig, W [1 ]
Locker, GY [1 ]
机构：
[1] Evanston NW Healthcare, Evanston, IL USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：337S / 337S
页数：1
相关论文
共 50 条
  • [21] Phase II capecitabine and gemcitabine fixed dose rate (FDR) in patients with advanced pancreatic cancer
    Santini, D.
    Vincenzi, B.
    Masi, G.
    Catalano, V
    Virzi, V.
    Vasile, E.
    Fontana, A.
    Intagliata, S.
    Catalano, G.
    Falcone, A.
    Tonini, G.
    ANNALS OF ONCOLOGY, 2008, 19 : 59 - 60
  • [22] A phase I trial of fixed dose rate gemcitabine and capecitabine in metastatic renal cell carcinoma
    Rini, BI
    Weinberg, V
    Small, EJ
    CANCER, 2005, 103 (03) : 553 - 558
  • [23] Phase I/II trial of doxorubicin and fixed dose-rate infusion gemcitabine in advanced soft tissue sarcomas: a GEIS study
    A López-Pousa
    R Losa
    J Martín
    J Maurel
    J Fra
    M Sierra
    A Casado
    J García del Muro
    A Poveda
    C Balañá
    J Martínez-Trufero
    E Esteban
    J M Buesa
    British Journal of Cancer, 2006, 94 : 1797 - 1802
  • [24] Phase I/II trial of doxorubicin and fixed dose-rate infusion gemcitabine in advanced soft tissue sarcomas:: a GEIS study
    Lopez-Pousa, A.
    Losa, R.
    Martin, J.
    Maurel, J.
    Fra, J.
    Sierra, M.
    Casado, A.
    Garcia del Muro, J.
    Poveda, A.
    Balana, C.
    Martinez-Trufero, J.
    Esteban, E.
    Buesa, J. M.
    BRITISH JOURNAL OF CANCER, 2006, 94 (12) : 1797 - 1802
  • [25] A phase I/II multicentric trial of gemcitabine and epirubicin in patients with advanced pancreatic carcinoma
    Eickhoff, A.
    Martin, W.
    Hartmann, D.
    Eickhoff, J. C.
    Moehler, M.
    Galle, P. R.
    Riemann, J. F.
    Jakobs, R.
    BRITISH JOURNAL OF CANCER, 2006, 94 (11) : 1572 - 1574
  • [26] Combining capecitabine and gemcitabine in patients with advanced pancreatic carcinoma: A phase I/II trial
    Hess, V
    Salzberg, M
    Borner, M
    Morant, R
    Roth, AD
    Ludwig, C
    Herrmann, R
    JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (01) : 66 - 68
  • [27] A phase I/II multicentric trial of gemcitabine and epirubicin in patients with advanced pancreatic carcinoma
    A Eickhoff
    W Martin
    D Hartmann
    J C Eickhoff
    M Möhler
    P R Galle
    J F Riemann
    R Jakobs
    British Journal of Cancer, 2006, 94 : 1572 - 1574
  • [28] Prolonged fixed dose rate infusion of gemcitabine with autologous haemopoietic support in advanced pancreatic adenocarcinoma
    C Bengala
    V Guarneri
    E Giovannetti
    M Lencioni
    E Fontana
    V Mey
    A Fontana
    U Boggi
    M Del Chiaro
    R Danesi
    S Ricci
    F Mosca
    M Del Tacca
    P F Conte
    British Journal of Cancer, 2005, 93 : 35 - 40
  • [29] Phase I trial of gemcitabine in patients with advanced pancreatic cancer
    Okada, S
    Ueno, H
    Okusaka, T
    Ikeda, M
    Furuse, J
    Maru, Y
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2001, 31 (01) : 7 - 12
  • [30] Prolonged fixed dose rate infusion of gemcitabine with autologous haemopoietic support in advanced pancreatic adenocarcinoma
    Bengala, C
    Guarneri, V
    Giovannetti, E
    Lencioni, M
    Fontana, E
    Mey, V
    Fontana, A
    Boggi, U
    Del Chiaro, M
    Danesi, R
    Ricci, S
    Mosca, F
    Del Tacca, M
    Conte, PF
    BRITISH JOURNAL OF CANCER, 2005, 93 (01) : 35 - 40
12345